In a study published in the American Journal of Clinical Pathology, a novel ELISA (enzyme-linked immunosorbent assay) was able to effectively differentiate between idiopathic and secondary membranous nephropathy. Serum samples were tested for the presence of anti-PLA2R1 using indirect immunofluorescence, Western blotting test, and ELISA. Both the Western blotting test and indirect immunofluorescence shared high agreement with ELISA.
Objectives: Autoantibodies against the M-type phospholipase A2 receptor 1 (anti-PLA2R1) have been demonstrated to be very specific for idiopathic membranous nephropathy (MN). We studied a novel enzyme-linked immunosorbent assay (ELISA) and compared results with results obtained using an indirect …
READ FULL ARTICLE
From ajcp.ascpjournals.org
Please login or register first to view this content.
You’ve read {{metering-count}} of {{metering-total}} articles this month.
We want you to take advantage of everything MPR has to offer. To view unlimited content, log in or register for free.
{{login-button}} {{register-button}}
Want to view more content from MPR?
Register now at no charge to access unlimited daily drug news, medication safety alerts & recalls, and industry-supported drug information & education.
{{login-button}} {{register-button}}
Please login or register first to view this content.
